52W Range | $12.49-$53 |
Market Cap | $406.5M |
Shares Short | 1M |
Revenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
CEO | Dr. Rachel L. McMinn Ph.D. |
CFO | Ms. Christine Mikail Cvijic J.D. |
Address | 535 W 24th Street, New York, NY, United States, 10011 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 91 |